Maliheh Khoddami1, Seyed Alireza Nadji2, Paria Dehghanian3. 1. Pediatric Pathology Research Center, Research Institute for Children Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 2. Virology Research Center (VRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran. 3. Pediatric Infections Research Center, Research Institute for Children Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Abstract
BACKGROUND AND OBJECTIVE: Langerhans cell histiocytosis (LCH) is a rare histiocytic proliferative disorder of unknown etiology and mainly affects young children. The histological feature is granuloma-like proliferation of langerhans-type dendritic cells. Although the possible role of viruses such as Epstein-Barr virus (EBV, Human Herpes virus -4), Human Herpes virus-6 (HHV-6), Herpes Simplex virus (HSV) types 1 and 2 and Cytomegalovirus (CMV, Human Herpes virus-5) is suggested in the pathogenesis of LCH by some investigators, its exact pathophysiology has not been cleared yet. In this study, we investigated the presence of HSV types 1 and 2 in Iranian children with LCH. METHODS: In this retrospective study, we investigated the prevalence of presence of HSV types 1 and 2 (in 30 patients with LCH), using paraffin-embedded tissue samples and 30 age and tissue-matched controls (operated for reasons other than infectious diseases) from the Department of Pediatric Pathology, Tehran, Iran, by nested Polymerase Chain reaction method. No ethical issues arose in the study, because only the pathology reports were reviewed and patients were anonymous. RESULTS: We failed to find HSV types 1 and 2 DNA in any of the 30 patients with LCH or the control group. CONCLUSION: According to our findings, HSV types 1 and 2 do not appear to have any etiologic role in the pathogenesis of LCH in Iranian children. These results are in accordance with previous investigations with negative findings.
BACKGROUND AND OBJECTIVE: Langerhans cell histiocytosis (LCH) is a rare histiocytic proliferative disorder of unknown etiology and mainly affects young children. The histological feature is granuloma-like proliferation of langerhans-type dendritic cells. Although the possible role of viruses such as Epstein-Barr virus (EBV, Human Herpes virus -4), Human Herpes virus-6 (HHV-6), Herpes Simplex virus (HSV) types 1 and 2 and Cytomegalovirus (CMV, Human Herpes virus-5) is suggested in the pathogenesis of LCH by some investigators, its exact pathophysiology has not been cleared yet. In this study, we investigated the presence of HSV types 1 and 2 in Iranian children with LCH. METHODS: In this retrospective study, we investigated the prevalence of presence of HSV types 1 and 2 (in 30 patients with LCH), using paraffin-embedded tissue samples and 30 age and tissue-matched controls (operated for reasons other than infectious diseases) from the Department of Pediatric Pathology, Tehran, Iran, by nested Polymerase Chain reaction method. No ethical issues arose in the study, because only the pathology reports were reviewed and patients were anonymous. RESULTS: We failed to find HSV types 1 and 2 DNA in any of the 30 patients with LCH or the control group. CONCLUSION: According to our findings, HSV types 1 and 2 do not appear to have any etiologic role in the pathogenesis of LCH in Iranian children. These results are in accordance with previous investigations with negative findings.
Authors: Andrew W Lee; Laura Hertel; Ryan K Louie; Timo Burster; Vashti Lacaille; Achal Pashine; Davide A Abate; Edward S Mocarski; Elizabeth D Mellins Journal: J Immunol Date: 2006-09-15 Impact factor: 5.422
Authors: Jon D Laman; Pieter J M Leenen; Nicola E Annels; Pancras C W Hogendoorn; R Maarten Egeler Journal: Trends Immunol Date: 2003-04 Impact factor: 16.687
Authors: Michael P Glotzbecker; John P Dormans; Bruce R Pawel; Brian P Wills; Yagnya Joshi; Michael Elkan; Richard L Hodinka Journal: J Orthop Res Date: 2006-03 Impact factor: 3.494
Authors: C L Willman; L Busque; B B Griffith; B E Favara; K L McClain; M H Duncan; D G Gilliland Journal: N Engl J Med Date: 1994-07-21 Impact factor: 91.245
Authors: Márta Csire; Gábor Mikala; János Jákó; Tamás Masszi; Judit Jánosi; János Dolgos; Tibor Füle; Attila Tordai; György Berencsi; István Vályi-Nagy Journal: Pathol Oncol Res Date: 2007-07-03 Impact factor: 2.874